Observational Program of Caelyx in MBC - Prevention and Treatment of PPE and Infusion Reactions.
Phase of Trial: Phase III
Latest Information Update: 12 Nov 2013
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- Sponsors Schering-Plough
- 07 Jun 2017 Biomarkers information updated
- 18 Nov 2010 Actual end date (Jun 2010 ) added as reported by ClinicalTrials.gov.
- 18 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.